Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...

In recent years, many patients like Mitchell have faced soaring insulin costs. These prices have been exacerbated by pharmacy benefit managers, or PBMs, middlemen between drug manufacturers and ...

want Federal Trade Commission Chair Lina Khan and two other commissioners to recuse themselves — or have the full commission remove them — from an agency insulin lawsuit. Attorneys for ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason ...

The Federal Trade Commission (FTC) has sued the top three ... system" that it claims artificially inflated the prices of insulin products. The lawsuit – which has been anticipated since the ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

The companies are accused by the Federal Trade Commission of engaging in anticompetitive practices that spur price increases. This is not the first time the cost of insulin has been under the ...

High insulin prices have been a hot topic in ... “The Biden administration, Congress, the Federal Trade Commission, and others need to do everything in their power to address the anti ...

CVS Health is one of three pharmacy benefit managers targeted in a lawsuit from the Federal Trade Commission, which has accused the companies of driving up the price of insulin. The three firms ...